[在服用普雷加巴林后出现双极性患者的自杀念头:一个案例报告]
Christine Wagner1, Augusto Montecino2
1Avi Medical, Berlin, Germany.
Fortschritte der Neurologie-Psychiatrie
|August 29, 2024
概括
这份病例报告强调了在双相II型精神障碍中使用普雷加巴林的潜在风险. 虽然它可以减少焦虑和酒精使用,但它与一个患者的自杀念头和自我伤害增加有关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性障碍是一种严重的精神疾病,经常与焦虑和滥用酒精一起发生.
- 抗抗药物普雷加巴林正在研究在治疗这些并发病时的潜在治疗益处.
研究的目的:
- 报告患有双相二极性障碍的病例,经历了与普雷加巴林的不良影响.
- 讨论普雷加巴林在治疗有情感障碍的患者中的有争议的作用.
主要方法:
- 一份病例报告详细介绍了一名37岁的女性患者,被诊断患有双相II型精神障碍.
- 观察患者对单独治疗奎平的反应,然后再添加普雷加巴林.
- 评估情绪,焦虑,饮酒和自杀行为变化.
主要成果:
- 添加普雷加巴林最初减少了焦虑和酒精消费,但加速了自杀念头和自我伤害行为.
- 停止服用普雷加巴林和增加提剂量导致自杀行为几乎消失.
- 文献综述表明,关于普雷加巴林在精神病患者的安全性和有效性的证据是相互矛盾的.
结论:
- 建议在患有情感障碍的患者中谨慎使用普雷加巴林和其他抗药物.
- 虽然普雷加巴林可能对并发症有好处,但它对情绪的影响需要进一步调查.
- 抗药可能增加自杀效应,因此需要仔细监测.
相关概念视频
Mania and Antimanic Drugs: Overview
155
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Bipolar Disorder
60
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
60
Antiepileptic Drugs: Potassium Channel Activators
150
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
150
Anxiolytic Drugs: Benzodiazepines and Buspirone
587
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
587
CNS Depressants: Barbiturates and Benzodiazepines
232
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
232
Borderline Personality Disorder
37
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
37


